Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 4 I, 1996, Pages 1013-1019

  Moore, Richard D ^a   Chaulk, C Patrick ^a   Griffiths, Robert ^a   Cavalcante, Solange ^a   Chaisson, Richard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMATE; RIFAMPICIN; RIFATER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TUBERCULOSIS; PRIORITY JOURNAL; SELF MEDICATION;

EID: 0029859358     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.4.8887600     Document Type: Article

References (35)

1. Reider, H. L., G. M. Cauthen, G. W. Comstock, and D. E. Snider. 1989. Epidemiology of tuberculosis in the United States. Epidemiol. Rev. 11:79-98.
2. Centers for Disease Control and Prevention. 1995. Tuberculosis Morbidity - United States, 1994. M.M.W.R. 44:4387-4395.
3. Frieden, T. R., J. Starling, A. Pablos-Mendez, J. U. Killman, G. M. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526.
4. Bloch, A. B., G. M. Cauthen, I. M. Onorato, K. G. Dansbury, G. D. Kelly, C. R. Driver, and D. E. Snider. 1994. Nationwide survey of drug-resistant tuberculosis in the United States. J.A.M.A. 271:665-671.
5. Brown, R. E., B. Miller, W. R. Taylor, C. Palmer, L. Bosco, R. M. Nicola, J. Zelinger, and K. Simpson. 1995. Health care expenditures for tuberculosis in the United States. Arch. Intern. Med. 155:1595-1600.
6. Rubel, A. J. and L. C. Garro. 1992. Social and cultural factors in the successful control of tuberculosis. Public Health Rep. 107:626-636.
7. Farmer, P., S. Robin, S. L. Ramilus, and J. Y. Kim. 1991. Tuberculosis, poverty and compliance: lessons from rural Haiti. Semin. Respir. Infect. 6:254-260.
8. Sumartojo, E. 1993. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am. Rev. Respir. Dis. 147:1311-1320.
9. Sbarbaro, J. A. 1985. Public health aspects of tuberculosis: supervision of therapy. Clin. Chest Med. 1:253-263.
10. Cohn, D. L., B. J. Catlin, K. L. Peterson, F. N. Judson, and J. A. Sbarbaro. 1990. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen. Ann. Intern. Med. 112:407-415.
11. Weis, S. E., P. C. Slocum, F. X. Biais, B. King, M. Nunn, B. Matney, E. Gomez, and B. H. Foresman. 1994. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N. Engl. J. Med. 330:1179-1184.
12. Chaulk, C. P., K. Rice-Moore, R. Rizzo, and R. E. Chaisson. 1995. 11-years of community-based directly observed therapy for tuberculosis. J.A.M.A. 274:945-951.
13. Iseman, M. D., D. L. Cohn, and J. A. Sbarbaro. 1993. Directly observed treatment of tuberculosis: we can't afford not to try. N. Engl. J. Med. 328:576-578.
14. American Thoracic Society and Centers for Disease Control and Prevention. 1994. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149:1359-1374.
15. Hong Kong Chest Service/British Medical Research Council. 1991. Controlled Trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Am. Rev. Respir. Dis. 143:700-706.
16. Singapore Tuberculosis Service/British Medical Research Council. 1991. Assessment of a daily preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Am. Rev. Respir. Dis. 143:707-712.
17. Combs, D. L., R. J. O'Brien, and L. J. Geiler. 1990. USPHS Tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity and acceptability. Ann. Intern. Med. 112:397-406.
18. Rosenblum, L. S., K. G. Castro, S. Dooley, and M. Morgan. 1994. Effect of HIV infection and tuberculosis on hospitalizations and cost of care for young adults in the United States, 1985 to 1990. Ann. Intern. Med. 121:786-792.
19. Anderson, G., P. Chaulk, and E. Fowler. 1993. Maryland: a regulatory approach to health system reform. Health Affairs 12:40-47.
20. Singapore Tuberculosis Service/British Medical Research Council. 1988. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Am. Rev. Respir. Dis. 137: 1147-1150.
21. Snider, D. E., J. Graczyk, E. Bek, and J. Rogowski. 1984. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Am. Rev. Respir. Dis. 130:1091-1094.
22. Hong Kong Chest Service/British Medical Research Council. 1982. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Tubercle 63:89-98.
23. Manalo, F., F. Tan, J. A. Sbarbaro, and M. D. Iseman. 1990. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Am. Rev. Respir. Dis. 142:1301-1305.
24. Hong Kong Chest Service/Tuberculosis Research Centre and Madras/British Medical Research Council. 1991. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am. Rev. Respir. Dis. 143:262-267.
25. Singapore Tuberculosis Service/British Medical Research Council. 1979. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am. Rev. Respir. Dis. 119:579-585.
26. East African/British Medical Research Council. 1972. Controlled clinical of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1:1079-1085.
27. Second East African/British Medical Research Council. 1974. Controlled clinical trial of our short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 2:1100-1106.
28. Hong Kong Chest Service/British Medical Research Council. 1978. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. Am. Rev. Respir. Dis. 118:219-227.
29. Goble, M., M. D. Iseman, L. A. Madsen, D. Waite, L. Ackerson, and C. R. Horsburgh. 1993. The treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N. Engl. J. Med. 328:527-532.
30. Small, P. M., G. F. Schecter, P. C. Goodman, M. A. Sande, R. E. Chaisson, and P. C. Hopewell. 1991. Treatment of tuberculosis in patients with advanced human immunodeficiency syndrome. N. Engl. J. Med. 324:289-294.
31. Perriers, J. H., M. E. St. Louis, Y. B. Mukadi, C. Brown, J. Prignot, F. Pouthier, F. Portaels, J. Willame, J. K. Mandala, M. Kaboto, R. W. Ryder, G. Roscigno, and P. Piot. 1995. Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N. Engl. J. Med. 332:779-784.
32. Blazes, D. L., K. Alwood, J. C. Keruly, K. Moore-Rice, R. D. Moore, and R. E. Chaisson. 1995. Effectiveness of short-course treatment of HIV-related tuberculosis (TB). J. Invest. Med. 43(Suppl. 2):369A.
33. Fischl, M. A., G. L. Daikos, R. B. Uttachandani, R. B. Poblete, J. N. Moreno, R. R. Reyes, A. M. Boota, L. M. Thompson, T. J. Cleary, S. A. Oldham, M. J. Saldana, and S. Lai. 1992. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann. Intern. Med. 117:184-190.
34. Centers for Disease Control and Prevention. 1995. Co-Incidence of HIV/AIDS and Tuberculosis - Chicago, 1982-1993. M.M.W.R. 44: 227-231.
35. Medical section of the American Lung Association/American Thoracic Society. 1992. Control of tuberculosis in the United States. Am. Rev. Respir. Dis. 146:1623-1633.